A Michigan Medicine physician-investigator and recipient of a Taubman Institute Innovation Projects (TIIP) grant will use samples from COVID-19 patients to study how the virus affects a patient’s immune profile. Daniel Goldstein, MD, last year began a TIIP study that will scrutinize the immune system of organ transplant patients in an effort to refine the…
By Ian Demsky Senior Writer, U-M Rogel Cancer Center How do a couple of universally expressed proteins in stem cells and developing embryos influence an individual cell’s ultimate fate — whether it ultimately becomes, for example, a retinal cell, a heart muscle cell, or a stomach lining cell? That’s the question that Rajesh C.…
The Taubman Institute will co-sponsor a new DNA sequencing project that aims to expand knowledge of the human genome and its role in disease. “Short Tandem Repeats in Precision Health and Human Disease” will be jointly supported by the institute and the Michigan Medicine Precision Health research initiative. The project is one of seven funded…
The 2019 Taubman Prize Symposium featured a keynote by prize recipient Professor Sir Stephen O’Rahilly, MD, of the University of Cambridge. Dr. O’Rahilly, an endocrinologist and researcher, spoke on “The Causes and Consequences of Human Obesity.” He accepted the award from Gayle Taubman Kalisman, PhD.
Their genius. Your generosity. The Taubman Institute extends its heartfelt appreciation to all of the donors who generously contributed to our Emerging Scholars on December 3, Giving Blueday. The laboratories of five researchers will receive your gifts in early January, helping them to further investigations into depression, autoimmune disorders, cancer, dementia and more. Thank you…
Improving outcomes for patients with aggressive brain tumors is the focus of the latest U-M faculty member to be named a Taubman Emerging Scholar. Daniel R. Wahl, MD, PhD, is an assistant professor in the department of Radiation Oncology. Dr. Wahl and his research team believe that targeting metabolic abnormalities may be the key to…
A physician-researcher studying life-threatening infections is the latest U-M faculty member to be named a Taubman Emerging Scholar. Scott Van Epps, MD, PhD, is an assistant professor in Emergency Medicine, Biomedical Engineering, and Macromolecular Science and Engineering. He also serves as an investigator for the Biointerfaces Institute and an associate director at the Michigan Center…
An endocrinologist whose paradigm-shifting work addresses the genetic causes of obesity and its adverse effect on metabolic health is the 2019 recipient of the Taubman Prize for Excellence in Medical Science, the University of Michigan’s Taubman Institute announced. Professor Sir Stephen O’Rahilly, M.D., of the University of Cambridge will receive the honor and the $100,000…
Taubman Emerging Scholar Michelle Kahlenberg, MD, PhD, has been named a recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE). by the White House. The PECASE is the highest honor bestowed by the United States Government to outstanding scientists and engineers who are beginning their independent research careers and who show exceptional…
The primary treatment for advanced or aggressive prostate cancer is to chemically or surgically short-circuit the body’s production of male hormones — called androgens — which drive the growth of the cancer cells. After a few years, however, the cancer invariably becomes resistant to this treatment, at which point it resumes its deadly progression. Now,…